search
Back to results

Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) in SUD Recovery (BBTI_SUDs)

Primary Purpose

Substance Use Disorders, Insomnia

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Brief Behavioral Therapy for Insomnia (BBTI)
Sponsored by
Johns Hopkins University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Substance Use Disorders focused on measuring Brief Behavioral Therapy for Insomnia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: client of Cornerstone Clinic (CC); resident at Helping Up Mission (HUM) active SUD ≥ 18 years old ISI ≥ 8 insomnia disorder as determined by Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Sleep Disorders (SIS-D) able to understand English proficiently Exclusion Criteria: medical or psychiatric condition interfering with treatment or requiring hospitalization inability to provide informed consent declines behavioral health treatment at CC suicidal ideation acute alcohol withdrawal requiring medical attention pregnant or breastfeeding moderate-severe sleep apnea based on WatchPAT restless legs syndrome based on SIS-D discharged from HUM

Sites / Locations

  • Cornerstone at Helping Up Mission ClinicRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

BBTI Group

SOC Group

Arm Description

Participants will receive 4 in-person sessions of Brief Behavioral Therapy for insomnia as part of their intensive outpatient treatment of substance use recovery

Participants will receive their usual substance abuse treatment as part of their intensive outpatient treatment of substance use recovery

Outcomes

Primary Outcome Measures

Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) as Assessed by the Success Rate of Outreach
The success rate of outreach is measured by: Percent of eligible Helping Up Mission (HUM) residents who were referred to study Percent of eligible HUM residents who consented to study Percent of HUM residents who attended BBTI Session 1 If overall score from the three parameters above is greater than 50%, outreach is feasible
Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) as Assessed by the Success Rate of Adoption
The success rate of adoption is measured by: Provider satisfaction with training as assessed by semi-structured interviews with Cornerstone Clinic researchers and staff, HUM leadership, and providers Provider satisfaction with facilitating BBTI as assessed by semi-structured interviews with participants If overall score from the parameters above is greater than 80%, adoption is feasible
Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) as Assessed by the Success Rate of Treatment Integrity
The success rate of treatment integrity is measured by percent of maintaining treatment based on fidelity checklist. If overall score is above 85% treatment integrity is feasible
Changes in the Symptoms of Insomnia after Brief Behavioral Therapy for Insomnia (BBTI) as Measured by Insomnia Severity Index (ISI)
Participants will complete ISI. Investigators will compare pre- and post-intervention primary outcomes. ISI is a 7-item questionnaire assessing the nature and symptoms of insomnia. ISI total score is the sum of all item scores which ranges from 0-28 and is interpreted as follows: no clinically significant insomnia (0-7), subthreshold insomnia (8-14), moderate clinical insomnia (15-21), and severe clinical insomnia (22-28). Negative changes in scores indicate improvement.
Changes in Sleep Efficiency after Brief Behavioral Therapy for Insomnia (BBTI) as Measured by Actigraphy
Participants in both arms will complete daily sleep diaries and wear an actiwatch. Sleep Efficiency is a measure of total sleep time over time in bed. Higher sleep efficiency indicates improved sleep.
Changes in Substance Used Outcome as Measured by Treatment Retention [days]
Treatment retention is number of days in substance used treatment. Treatment retention days will be counted by the number of days that the client is in treatment at the Helping Up Mission.

Secondary Outcome Measures

Treatment Satisfaction Rate as Assessed by Treatment Satisfaction Survey
Participants will complete a treatment satisfaction survey at the end of each BBTI session. Response options are coded from 1 to 4. The total score ranges from 5 to 20 with a higher score indicating a greater satisfaction rate.
Treatment Adherence Rate as Assessed by Treatment Adherence
Treatment adherence is a measurement of BBTI sessions attended.
Maintenance of Intervention
Maintenance of intervention is a measurement of treatment availability over one year.
Post-treatment Substance Use Disorder Relapse Rate as Assessed by Treatment Retention [days]
Relapse Rate is percent of positive urine toxicology results. Treatment retention days will be counted by the number of days that the client is in treatment at the Helping Up Mission.
Change in Quality of life as Measured by PROMIS Global Health Scale
Participants will complete the PROMIS Global Health Scale post-intervention. This is a 10-item patient-reported questionnaire that assesses healthcare-related quality of life measures. The results of the questions are used to calculate two summary scores: a Global Physical Health Score and a Global Mental Health Score. The scores are standardized to the general population, using the "T-score" which is 50 points with a standard deviation of 10. Higher scores indicate better health.
Change in Depression Measured by PROMIS Depression Scale
Participants will complete PROMIS Depression Scale questionnaires at pre-treatment and post-treatment. This is a 4-item questionnaire that assesses depressed mood in the past 7 days. The total score ranges from 8 to 40 with higher scores indicating greater severity of depression. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.
Change in Anxiety Measured by PROMIS Anxiety Scale
Participants will complete the PROMIS Anxiety Scale questionnaires at pre-treatment and post-treatment. This is a 4-item questionnaire that assesses the severity of the individual's anxiety in the past 7 days. The total score ranges from 7 to 35 with higher scores indicating greater severity of anxiety. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.
Change in Pain Measured by PROMIS Pain Interference Scale
Participants will complete the PROMIS Pain Interference questionnaire at pre-treatment and post-treatment This is a 4-item questionnaire that assesses pain interference in the last 7 days. The total score ranges from 4 to 20 with higher scores indicating greater pain interference with daily activities. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.
Change in Pain Measured by PROMIS Pain Severity Scale
Participants will complete the PROMIS Pain Severity questionnaire at pre-treatment and post-treatment This is a 4-item questionnaire that assesses pain intensity in the past 7 days. The total score ranges from 3 to 9 with higher scores indicating severe pain. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.

Full Information

First Posted
June 29, 2023
Last Updated
September 7, 2023
Sponsor
Johns Hopkins University
search

1. Study Identification

Unique Protocol Identification Number
NCT05935735
Brief Title
Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) in SUD Recovery
Acronym
BBTI_SUDs
Official Title
Using Implementation Science to Examine the Feasibility and Efficacy of Brief Behavioral Therapy for Insomnia (BBTI) in Substance Use Disorder Recovery Programs
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 26, 2023 (Actual)
Primary Completion Date
September 2025 (Anticipated)
Study Completion Date
December 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this clinical study is to learn whether treating sleep problems is helpful in people with substance abuse problems who are living in a residential treatment program. Another goal is to study whether treating sleep problems will help individuals stay in substance abuse recovery treatment for a greater amount of time. Participants will be asked to complete surveys at the time of enrollment and every week for the next 9 weeks for a total of 8 times. Participants will be asked to wear a watch that measures sleep (sleep watch) while the participants are in the group and for a 2-week period after the participants complete the group. Participants may also be asked to participate in an interview about the experience with the group and wearing the watch. Participants will also have "homework" throughout a 4 week period. Homework is to complete a sleep diary each morning. The first group of 50 participants will be enrolled in the brief behavioral treatment for insomnia (BBTI) group where the participants receive typical treatment plus the sleep intervention program. The investigators will use qualitative and quantitative data to identify implementation facilitators and barriers, then further modify BBTI to improve feasibility. After modifying the BBTI protocol and re-training staff, study procedures will remain intact with the exception that the investigators will double the recruitment and randomize participants to the modified BBTI (N=50) or standard-of-care (SOC) (N=50). All participants will complete all assessments except the SOC group will not complete treatment satisfaction surveys.
Detailed Description
Brief behavioral treatment for insomnia (BBTI) is an efficacious evidence-based sleep intervention derived from cognitive behavioral therapy for insomnia (CBT-I) that may address barriers to widespread dissemination of insomnia therapy because it is brief (4 weeks), easily deliverable without need for specialty training (uses a hard-copy workbook) and behaviorally-focused. This proposal has the following two aims: To use the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework, a well-established implementation framework that informs evaluation of health-related programs, including in community and substance use treatment settings, to evaluate the feasibility of implementing a modified BBTI among underserved special population of individuals in a residential recovery program; To conduct a clinical trial to evaluate the efficacy of the modified BBTI on subjective and objective sleep outcomes compared with conventional standard-of-care. The end goal of this project is to provide empirical evidence of a modified BBTI's value in SUD recovery for individuals of diverse racial backgrounds. Successful completion of this study will promote the dissemination and sustainable adoption of an evidence-based, pragmatic, and accessible insomnia intervention in real-world SUD recovery programs.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance Use Disorders, Insomnia
Keywords
Brief Behavioral Therapy for Insomnia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
BBTI Group
Arm Type
Experimental
Arm Description
Participants will receive 4 in-person sessions of Brief Behavioral Therapy for insomnia as part of their intensive outpatient treatment of substance use recovery
Arm Title
SOC Group
Arm Type
No Intervention
Arm Description
Participants will receive their usual substance abuse treatment as part of their intensive outpatient treatment of substance use recovery
Intervention Type
Behavioral
Intervention Name(s)
Brief Behavioral Therapy for Insomnia (BBTI)
Intervention Description
4 in-person sessions; 1 individual and 3 group sessions
Primary Outcome Measure Information:
Title
Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) as Assessed by the Success Rate of Outreach
Description
The success rate of outreach is measured by: Percent of eligible Helping Up Mission (HUM) residents who were referred to study Percent of eligible HUM residents who consented to study Percent of HUM residents who attended BBTI Session 1 If overall score from the three parameters above is greater than 50%, outreach is feasible
Time Frame
Up to 1 year
Title
Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) as Assessed by the Success Rate of Adoption
Description
The success rate of adoption is measured by: Provider satisfaction with training as assessed by semi-structured interviews with Cornerstone Clinic researchers and staff, HUM leadership, and providers Provider satisfaction with facilitating BBTI as assessed by semi-structured interviews with participants If overall score from the parameters above is greater than 80%, adoption is feasible
Time Frame
Up to 1 year
Title
Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) as Assessed by the Success Rate of Treatment Integrity
Description
The success rate of treatment integrity is measured by percent of maintaining treatment based on fidelity checklist. If overall score is above 85% treatment integrity is feasible
Time Frame
Up to 1 year
Title
Changes in the Symptoms of Insomnia after Brief Behavioral Therapy for Insomnia (BBTI) as Measured by Insomnia Severity Index (ISI)
Description
Participants will complete ISI. Investigators will compare pre- and post-intervention primary outcomes. ISI is a 7-item questionnaire assessing the nature and symptoms of insomnia. ISI total score is the sum of all item scores which ranges from 0-28 and is interpreted as follows: no clinically significant insomnia (0-7), subthreshold insomnia (8-14), moderate clinical insomnia (15-21), and severe clinical insomnia (22-28). Negative changes in scores indicate improvement.
Time Frame
Baseline and post intervention up to 4 weeks
Title
Changes in Sleep Efficiency after Brief Behavioral Therapy for Insomnia (BBTI) as Measured by Actigraphy
Description
Participants in both arms will complete daily sleep diaries and wear an actiwatch. Sleep Efficiency is a measure of total sleep time over time in bed. Higher sleep efficiency indicates improved sleep.
Time Frame
Baseline and post intervention up to 4 weeks
Title
Changes in Substance Used Outcome as Measured by Treatment Retention [days]
Description
Treatment retention is number of days in substance used treatment. Treatment retention days will be counted by the number of days that the client is in treatment at the Helping Up Mission.
Time Frame
Baseline and post intervention up to 4 weeks
Secondary Outcome Measure Information:
Title
Treatment Satisfaction Rate as Assessed by Treatment Satisfaction Survey
Description
Participants will complete a treatment satisfaction survey at the end of each BBTI session. Response options are coded from 1 to 4. The total score ranges from 5 to 20 with a higher score indicating a greater satisfaction rate.
Time Frame
5 Weeks
Title
Treatment Adherence Rate as Assessed by Treatment Adherence
Description
Treatment adherence is a measurement of BBTI sessions attended.
Time Frame
5 Weeks
Title
Maintenance of Intervention
Description
Maintenance of intervention is a measurement of treatment availability over one year.
Time Frame
Up to 1 year
Title
Post-treatment Substance Use Disorder Relapse Rate as Assessed by Treatment Retention [days]
Description
Relapse Rate is percent of positive urine toxicology results. Treatment retention days will be counted by the number of days that the client is in treatment at the Helping Up Mission.
Time Frame
Up to 4 weeks post intervention
Title
Change in Quality of life as Measured by PROMIS Global Health Scale
Description
Participants will complete the PROMIS Global Health Scale post-intervention. This is a 10-item patient-reported questionnaire that assesses healthcare-related quality of life measures. The results of the questions are used to calculate two summary scores: a Global Physical Health Score and a Global Mental Health Score. The scores are standardized to the general population, using the "T-score" which is 50 points with a standard deviation of 10. Higher scores indicate better health.
Time Frame
Baseline and post intervention up to 4 weeks
Title
Change in Depression Measured by PROMIS Depression Scale
Description
Participants will complete PROMIS Depression Scale questionnaires at pre-treatment and post-treatment. This is a 4-item questionnaire that assesses depressed mood in the past 7 days. The total score ranges from 8 to 40 with higher scores indicating greater severity of depression. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.
Time Frame
Baseline and post intervention up to 4 weeks
Title
Change in Anxiety Measured by PROMIS Anxiety Scale
Description
Participants will complete the PROMIS Anxiety Scale questionnaires at pre-treatment and post-treatment. This is a 4-item questionnaire that assesses the severity of the individual's anxiety in the past 7 days. The total score ranges from 7 to 35 with higher scores indicating greater severity of anxiety. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.
Time Frame
Baseline and post intervention up to 4 weeks
Title
Change in Pain Measured by PROMIS Pain Interference Scale
Description
Participants will complete the PROMIS Pain Interference questionnaire at pre-treatment and post-treatment This is a 4-item questionnaire that assesses pain interference in the last 7 days. The total score ranges from 4 to 20 with higher scores indicating greater pain interference with daily activities. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.
Time Frame
Baseline and post intervention up to 4 weeks
Title
Change in Pain Measured by PROMIS Pain Severity Scale
Description
Participants will complete the PROMIS Pain Severity questionnaire at pre-treatment and post-treatment This is a 4-item questionnaire that assesses pain intensity in the past 7 days. The total score ranges from 3 to 9 with higher scores indicating severe pain. Then, the total score is converted into T-score which is 50 points with a standard deviation of 10. Negative changes in the score indicate improvement.
Time Frame
Baseline and post intervention up to 4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: client of Cornerstone Clinic (CC); resident at Helping Up Mission (HUM) active SUD ≥ 18 years old ISI ≥ 8 insomnia disorder as determined by Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Sleep Disorders (SIS-D) able to understand English proficiently Exclusion Criteria: medical or psychiatric condition interfering with treatment or requiring hospitalization inability to provide informed consent declines behavioral health treatment at CC suicidal ideation acute alcohol withdrawal requiring medical attention pregnant or breastfeeding moderate-severe sleep apnea based on WatchPAT restless legs syndrome based on SIS-D discharged from HUM
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Traci J Speed, MD/PHD
Phone
410-550-7985
Email
speed@jhmi.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Denis Antoine, MD
Phone
410-550-2796
Email
antoine@jhmi.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Traci J Speed, MD/PHD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cornerstone at Helping Up Mission Clinic
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21203
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Denis Antoine, MD
Phone
410-550-2796
Ext
112
Email
antoine@jhmi.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) in SUD Recovery

We'll reach out to this number within 24 hrs